<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04911218</url>
  </required_header>
  <id_info>
    <org_study_id>1762/22.01.21</org_study_id>
    <nct_id>NCT04911218</nct_id>
  </id_info>
  <brief_title>GlideSheath Slender® Versus Conventional 5Fr Arterial Sheath in Coronary Angiography Through the Distal Radial Artery</brief_title>
  <official_title>Randomized Comparison of GlideSheath Slender® Versus Conventional 5Fr Arterial Sheath in Coronary Angiography Through the Distal Radial Artery (Anatomical Snuffbox)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of Patras</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital of Patras</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Transradial approach has become the default arterial access for coronary angiography (CAG)&#xD;
      and percutaneous coronary intervention (PCI), mainly due to lower incidence of bleeding&#xD;
      compared to transfemoral access.1 However, TRA is not deprived of local access site&#xD;
      complications such as radial artery occlusion (RAO), occurring in approximately 5.2% of&#xD;
      patients, compartment syndrome, pseudoaneurysm, hematoma, and arteriovenous fistula.&#xD;
      Recently, a novel approach has been proposed, the access through the distal radial artery&#xD;
      (distal transradial access, dTRA), located in the anatomical snuffbox. Initial studies&#xD;
      regarding the dRA have shown feasibility and benefits, including shorter hemostasis time,&#xD;
      fewer local access site complications and potentially lower incidence of RAO.&#xD;
&#xD;
      GlideSheath Slender is a novel sheath which has a hydrophilic coating and is made of a&#xD;
      thinner material than traditional sheaths. As a result, the external diameter of the 5 Fr&#xD;
      GlideSheath Slender sheath is 1 Fr lower compared with conventional arterial sheaths.&#xD;
&#xD;
      The purpose of the present study was to investigate whether the use of the Slender sheath&#xD;
      affects the time of hemostasis, sheath insertion time, crossover rate to conventional radial&#xD;
      access, pain associated with the procedure and incidence of local access site complications&#xD;
      (RAO, distal radial artery occlusion, fistula, hematoma) in patients undergoing diagnostic&#xD;
      angiography through the distal radial artery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients fulfilling the enrollment criteria will be randomized 1:1 to GlideSheath Slender&#xD;
      versus conventional 5Fr arterial sheath for access through the distal radial artery (dTRA).&#xD;
      In case an interventional procedure is required then the initial sheath will be exchanged to&#xD;
      a larger sheath according to the circumstances of the case and the patient will not be&#xD;
      included in the analysis.&#xD;
&#xD;
      For randomized patients sheath insertion time, necessity for crossover to conventional radial&#xD;
      access, pain associated with the procedure (visual pain scale) and occurrence of hematoma&#xD;
      will be recorded. Follow-up ultrasound 7-10 days after the procedure for detection of RAO,&#xD;
      distal radial artery occlusion and fistula formation will be performed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 10, 2021</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of successful hemostasis at 30 minutes after sheath removal</measure>
    <time_frame>At 30 minutes after sheath removal</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Crossover rate to conventional radial access</measure>
    <time_frame>During the procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain associated with the procedure (visual analog scale, VAS)</measure>
    <time_frame>During the procedure</time_frame>
    <description>0-10, 0: no pain, 10: worst pain possible</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of hematoma modified EASY class≥II</measure>
    <time_frame>Up to 24 hours after hemostatic device removal</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of forearm radial artery occlusion</measure>
    <time_frame>7-10 days after the coronary angiography</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of distal radial artery occlusion</measure>
    <time_frame>7-10 days after the coronary angiography</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of fistula formation</measure>
    <time_frame>7-10 days after the coronary angiography</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of pseudoaneurysm formation</measure>
    <time_frame>7-10 days after the coronary angiography</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Arterial Access</condition>
  <condition>Coronary Angiography</condition>
  <condition>Radial Artery Occlusion</condition>
  <arm_group>
    <arm_group_label>GlideSheath Slender 5Fr arterial sheath</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Placement of GlideSheath Slender 5Fr arterial sheath for diagnostic angiography through the distal radial artery (anatomical snuffbox).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional 5Fr arterial sheath</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Placement of Conventional 5Fr arterial sheath arterial sheath for diagnostic angiography through the distal radial artery (anatomical snuffbox).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GlideSheath Slender 5Fr arterial sheath</intervention_name>
    <description>Placement of GlideSheath Slender 5Fr arterial sheath for coronary angiography through the distal radial artery (anatomical snuffbox).</description>
    <arm_group_label>GlideSheath Slender 5Fr arterial sheath</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Conventional 5Fr arterial sheath</intervention_name>
    <description>Placement of conventional 5Fr arterial sheath for coronary angiography through the distal radial artery (anatomical snuffbox).</description>
    <arm_group_label>Conventional 5Fr arterial sheath</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Indication for coronary angiography&#xD;
&#xD;
          -  Age&gt;18 years&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Non-palpable right radial artery&#xD;
&#xD;
          -  Prior CABG&#xD;
&#xD;
          -  STEMI&#xD;
&#xD;
          -  Prior right transaradial intervention within the previous 2 months&#xD;
&#xD;
          -  Hemodynamic instability&#xD;
&#xD;
          -  Anatomical restrictions (fistula orthopaedic problems, etc)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Grigorios Tsigkas, MD, PhD</last_name>
    <phone>+306974466662</phone>
    <email>gregtsig@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital of Patras</name>
      <address>
        <city>Patras</city>
        <state>Achaia</state>
        <zip>26504</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Grigorios Tsigkas</last_name>
      <phone>00306974466662</phone>
      <email>gregtsig@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Athanasios Moulias</last_name>
      <phone>+306945977047</phone>
      <email>dramoulias@live.com</email>
    </contact_backup>
    <investigator>
      <last_name>Grigorios Tsigkas, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Periklis Davlouros, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Athanasios Moulias, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>May 20, 2021</study_first_submitted>
  <study_first_submitted_qc>May 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 2, 2021</study_first_posted>
  <last_update_submitted>October 11, 2021</last_update_submitted>
  <last_update_submitted_qc>October 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital of Patras</investigator_affiliation>
    <investigator_full_name>Grigorios Tsigkas</investigator_full_name>
    <investigator_title>Assistant Professor of Cardiology</investigator_title>
  </responsible_party>
  <keyword>arterial access</keyword>
  <keyword>coronary angiography</keyword>
  <keyword>radial access</keyword>
  <keyword>distal radial access</keyword>
  <keyword>radial artery occlusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arterial Occlusive Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

